Cost-Effective Strategies for Rabies Vaccination in Low-Income Countries
Author Information
Author(s): Hampson Katie, Cleaveland Sarah, Briggs Deborah, Zinsstag Jakob
Primary Institution: Boyd Orr Centre for Population and Ecosystem Health, University of Glasgow
Hypothesis
Switching from intramuscular to intradermal administration of rabies post-exposure prophylaxis (PEP) will improve cost-effectiveness and accessibility.
Conclusion
Intradermal delivery of rabies PEP is more cost-effective than intramuscular delivery, potentially reducing human rabies deaths and improving vaccine accessibility.
Supporting Evidence
- PEP vaccination can be extremely cost-effective, costing from $200 to less than $60 per death averted.
- Switching to intradermal regimens can significantly reduce the volume of vaccine required.
- High throughput clinics benefit the most from cost-effective ID vaccination strategies.
- ID vaccination can mitigate vaccine shortages and improve accessibility for bite victims.
Takeaway
If we give rabies shots in a different way, we can save money and help more people get the shots they need to stay safe from rabies.
Methodology
The study analyzed different PEP vaccination regimens and evaluated their costs and benefits using a simulation framework.
Limitations
The study assumes that all patients comply with vaccination schedules, which may not reflect real-world scenarios.
Participant Demographics
The study focuses on bite victims in low-income countries, particularly in Africa and Asia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website